Literature DB >> 11354665

Identification of inhibitors of heparin-growth factor interactions from combinatorial libraries of four-component condensation reactions.

J Zhang1, G Riverst, Y Zhu, A Jacobson, J Peyers, G Grundstrom, P Burch, S Hussein, A Marolewski, W Herlihy, J Rusche.   

Abstract

Chemical libraries based on four-component condensation (4CC) reactions of isocyanides were constructed to identify compounds capable of blocking heparin binding to vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF). The reaction products in the synthesized libraries contain heparin mimetic functional groups such as carbohydrates, sulfonates, carboxylates, and hydroxy groups. These libraries have been screened for the inhibition of heparin binding to growth factors such as VEGF and bFGF. Single point screening at 5.0 microM of the 18,720 reaction products generated 26 candidates. The IC50S of these 26 compounds were determined using HPLC-purified products and 20 of the 26 showed significant inhibition of heparin binding to VEGF and/or bFGF. Eighteen of the 20 confirmed active compounds have a linear extended structure. Structures identified in this library revealed an initial relationship of structure and activity, thus providing direction for further investigation of this type of heparin mimetic libraries.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11354665     DOI: 10.1016/s0968-0896(00)00317-5

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  4 in total

1.  Surfen, a small molecule antagonist of heparan sulfate.

Authors:  Manuela Schuksz; Mark M Fuster; Jillian R Brown; Brett E Crawford; David P Ditto; Roger Lawrence; Charles A Glass; Lianchun Wang; Yitzhak Tor; Jeffrey D Esko
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-25       Impact factor: 11.205

2.  Synthesis of disaccharides containing 6-deoxy-α-L-talose as potential heparan sulfate mimetics.

Authors:  Jon K Fairweather; Ligong Liu; Tomislav Karoli; Vito Ferro
Journal:  Molecules       Date:  2012-08-15       Impact factor: 4.411

Review 3.  Heparin/Heparan sulfate proteoglycans glycomic interactome in angiogenesis: biological implications and therapeutical use.

Authors:  Paola Chiodelli; Antonella Bugatti; Chiara Urbinati; Marco Rusnati
Journal:  Molecules       Date:  2015-04-10       Impact factor: 4.411

Review 4.  Heparin Binding Proteins as Therapeutic Target: An Historical Account and Current Trends.

Authors:  Giancarlo Ghiselli
Journal:  Medicines (Basel)       Date:  2019-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.